The objective of this task order is to commission a patient preference study in opioid use disorder (OUD) to better understand the point of view of the patients, family members, and health care…
Ended Awarded Last action
- Contract number
- 75F40122F19027
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $499,770
Award facts
- Contract value 100% obligated
- $499,770.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- B599 Special Studies/Analysis- Other
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $499,770 |
About this award
The Food and Drug Administration issued a BPA call to Research Triangle Institute on September 16, 2022, with a ceiling value of $499,770.00 for a patient preference study in opioid use disorder. The call was placed under the FDA's Quick Turnaround Social Science Research Services BPA (valued at $70 million through December 2030).
The task order commissions a study to understand the perspectives of patients, family members, and healthcare providers affected by opioid use disorder. Work is performed in Silver Spring, Maryland. The original delivery date of September 18, 2024, was modified to February 7, 2025. The contract carries firm fixed-price pricing.
Description
The objective of this task order is to commission a patient preference study in opioid use disorder (OUD) to better understand the point of view of the patients, family members, and health care providers affected by opioid use disorder. We aim on RE
Quick answers
Who was awarded contract 75F40122F19027?
75F40122F19027 was awarded to Research Triangle Institute by Food and Drug Administration (Department of Health and Human Services) on September 16, 2022.
How much is contract 75F40122F19027 worth?
The government has obligated $499,770 on 75F40122F19027.
Is contract 75F40122F19027 an order under another contract?
Yes. 75F40122F19027 is a BPA call under GS00F354CA-75F40120A00017, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40122F19027 competed?
The extent of competition for 75F40122F19027 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award